dockets: BIS-2025-0022

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
BIS-2025-0022 BIS Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients Nonrulemaking 2025-05-29T20:21:12Z 0b00006486a8dfea   The Secretary of Commerce initiated an investigation to determine the effects on the national security of imports of pharmaceuticals and pharmaceutical ingredients, including finished drug products, medical countermeasures, and critical inputs such as active pharmaceutical ingredients, and key starting materials – as well as derivative products. This investigation has been initiated under section 232 of the Trade Expansion Act of 1962, as amended. Interested parties are invited to submit written comments, data, analyses, or other information pertinent to the investigation to the Department of Commerce’s Bureau of Industry and Security. This notice identifies issues on which the Department is especially interested in obtaining the public’s views.     ["Section 232", "pharmaceuticals", "Country specific", "Item specific", "Use/user"]         {"displayProperties": [{"name": "abstract", "label": "Description", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Docket Subject, General Info, Related To, Summary."}], "keywords": ["Section 232", "pharmaceuticals", "Country specific", "Item specific", "Use/user"], "modifyDate": "2025-05-29T20:21:12Z", "dkAbstract": "The Secretary of Commerce initiated an investigation to determine the effects on the national security of imports of pharmaceuticals and pharmaceutical ingredients, including finished drug products, medical countermeasures, and critical inputs such as active pharmaceutical ingredients, and key starting materials \u2013 as well as derivative products. This investigation has been initiated under section 232 of the Trade Expansion Act of 1962, as amended. Interested parties are invited to submit written comments, data, analyses, or other information pertinent to the investigation to the Department of Commerce\u2019s Bureau of Industry and Security. This notice identifies issues on which the Department is especially interested in obtaining the public\u2019s views.", "agencyId": "BIS", "program": null, "shortTitle": null, "subType2": null, "title": "Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients", "generic": null, "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006486a8dfea"} single_get

Links from other tables